Abstract
AMP-activated protein kinase (AMPK) is an important regulator of glucose metabolism, and glucose transporter 3 (GLUT3) is an efficient glucose transporter in trophoblasts. Whether placental AMPK and GLUT3 respond accordingly to gestational diabetes mellitus (GDM) remains uncertain. Here, we explored the regulatory role of AMPK in the GLUT3-dependent uptake of glucose by placental trophoblasts and the viability of the cells. In this study, the level of glycolysis in normal and GDM-complicated placentas was assessed by LC-MS/MS. The trophoblast hyperglycemia model was induced by the incubation of HTR8/SVneo cells with a high glucose concentration. GDM animal models were generated with db/ + mice and C57BL/6J mice fed a high-fat diet, and AMPK was manipulated by the oral administration of metformin. The uptake of glucose by trophoblasts was assessed using 2-NBDG or 2-deoxy-D-[<sup>3</sup>H] glucose. The results showed that GDM is associated with impaired glycolysis, AMPK activity, GLUT3 expression in the plasma membrane (PM) and cell survival in the placenta. Hyperglycemia induced similar changes in trophoblasts, and these changes were rescued by AMPK activation. Both hyperglycemic db/ + and high-fat diet-induced GDM mice exhibited a compromised AMPK-GLUT3 axis and suppressed cell viability in the placenta as well as excessive fetal growth, and all of these effects were partially alleviated by metformin. Taken together, our findings support the notion that AMPK activation upregulates trophoblast glucose uptake by stimulating GLUT3 translocation, which is beneficial for viability. Thus, the modulation of glucose metabolism in trophoblasts by targeting AMPK might ameliorate the adverse intrauterine environment caused by GDM.
Introduction
Gestational Diabetes Mellitus (GDM) is a prevalent pregnancy complication, affecting up to 20% of pregnancies worldwide. It is characterized by maternal hyperglycemia and is associated with significant long-term metabolic risks for both the mother and the offspring. While the systemic effects of GDM are well-documented, the precise molecular mechanisms by which a high-glucose environment impairs placental function—specifically within the trophoblasts that mediate nutrient transfer—remain a subject of intense investigation. This study explores the hypothesis that hyperglycemia paradoxically induces a state of cellular energy crisis in the placenta by disrupting the AMPK-GLUT3 signaling axis.
Methodology
To investigate these mechanisms, researchers utilized a multi-faceted approach combining human tissue analysis, in vitro cell models, and in vivo animal studies.
- Human Samples: Placentas were collected from 32 GDM-complicated and 30 healthy full-term pregnancies.
- Cellular Models: Human trophoblast cell lines (HTR8/SVneo and BeWo) were cultured under high-glucose conditions to simulate the GDM environment.
- Animal Models: The study employed both a genetic GDM model ($db/+$ mice) and a diet-induced model (C57BL/6J mice on a high-fat diet).
- Analytical Techniques: Glycolytic intermediates were quantified using LC-MS/MS, while cellular bioenergetics were assessed via Seahorse metabolic assays. Protein expression and subcellular localization were determined through Western blotting and immunofluorescence.
Key Findings
Downregulation of the AMPK Pathway
A central discovery of this research is the significant suppression of AMP-activated protein kinase (AMPK) activity in GDM placentas. AMPK serves as a metabolic "master switch" that senses cellular energy status. Western blot analysis revealed a marked decrease in the phosphorylation of AMPK at Thr172 in GDM samples, indicating reduced activation despite similar levels of total AMPK protein.
Impaired GLUT3 Trafficking and Glucose Uptake
The study found that while total GLUT3 protein levels might not be drastically altered, its trafficking to the plasma membrane (PM) is severely compromised under hyperglycemic conditions. GLUT3 is a high-affinity glucose transporter crucial for trophoblast function. Immunofluorescence imaging confirmed the presence of GLUT3 in trophoblasts (identified by CK-7 staining), but functional assays showed that high glucose reduced glucose uptake by approximately 30%, corresponding to a 50% reduction in membrane-bound GLUT3.
Cellular Consequences and Rescue by Metformin
The impairment of the AMPK-GLUT3 axis leads to reduced glycolysis and decreased trophoblast viability, characterized by increased apoptosis and reduced proliferation. Interestingly, the study demonstrated that these effects could be reversed. Activating AMPK with AICAR in vitro or Metformin in vivo restored GLUT3 membrane localization and improved cell survival. In animal models, metformin treatment also mitigated the excessive fetal growth typically seen in GDM.
Discussion and Future Directions
This research highlights a "starvation in the midst of plenty" phenomenon, where placental cells are unable to utilize the abundant glucose available due to trafficking defects. While the study establishes a clear link between AMPK and GLUT3 trafficking, the specific molecular motors or tethering proteins involved in this process remain to be identified. Furthermore, while metformin shows promise in restoring placental health, distinguishing its direct effects on the placenta from its systemic glucose-lowering effects is a challenge for future clinical research. These findings suggest that targeting the placental AMPK-GLUT3 axis could offer new therapeutic avenues for managing the adverse intrauterine environment in GDM.
Summary updated